Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $67.46 | 5 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $41.91 | 3 | $0 (2017) |
| Relypsa, Inc. | $13.93 | 1 | $0 (2017) |
| AbbVie Inc. | $11.62 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $11.62 | 1 | AbbVie Inc. ($11.62) |
| 2017 | $55.84 | 4 | Allergan Inc. ($41.91) |
All Payment Transactions
5 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/24/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $11.62 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/02/2017 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/26/2017 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $13.93 | General |
| Category: Hyperkalemia | ||||||
| 08/31/2017 | Allergan Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/29/2017 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 238 | 245 | $562,473 | $33,062 |
| 2022 | 4 | 301 | 304 | $657,160 | $45,151 |
| 2021 | 4 | 332 | 340 | $722,396 | $52,143 |
| 2020 | 5 | 437 | 453 | $947,130 | $65,192 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 132 | 136 | $304,368 | $18,135 | 6.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 66 | 68 | $195,908 | $11,444 | 5.8% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 40 | 41 | $62,197 | $3,483 | 5.6% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 174 | 175 | $389,804 | $26,876 | 6.9% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 65 | 67 | $190,665 | $13,515 | 7.1% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 45 | 45 | $65,689 | $3,919 | 6.0% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 17 | 17 | $11,003 | $841.10 | 7.6% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 199 | 205 | $451,330 | $32,574 | 7.2% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 77 | 78 | $224,718 | $16,025 | 7.1% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 34 | 34 | $43,795 | $3,400 | 7.8% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 22 | 23 | $2,553 | $144.54 | 5.7% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 259 | 272 | $604,796 | $41,220 | 6.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 95 | 98 | $279,943 | $20,104 | 7.2% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 30 | 30 | $45,510 | $2,809 | 6.2% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 16 | 16 | $12,800 | $810.74 | 6.3% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2020 | 37 | 37 | $4,081 | $248.74 | 6.1% |
About Dr. Thuytien Do, MD
Dr. Thuytien Do, MD is a Emergency Medicine healthcare provider based in Metairie, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1669564159.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thuytien Do, MD has received a total of $67.46 in payments from pharmaceutical and medical device companies, with $11.62 received in 2021. These payments were reported across 5 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($67.46).
As a Medicare-enrolled provider, Do has provided services to 1,308 Medicare beneficiaries, totaling 1,342 services with total Medicare billing of $195,548. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Location Metairie, LA
- Active Since 09/29/2006
- Last Updated 12/11/2018
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1669564159
Products in Payments
- DALVANCE (Drug) $38.89
- TEFLARO (Drug) $14.64
- Veltassa (Drug) $13.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Metairie
Dr. Patrick Bonneval, M.d, M.D
Emergency Medicine — Payments: $781.76
Mr. Travis Hill, Md, MD
Emergency Medicine — Payments: $688.71
Dr. Jamie Broussard, Md, MD
Emergency Medicine — Payments: $514.01
Dr. Samir Khalaf, M.d, M.D
Emergency Medicine — Payments: $246.10
Dr. William Elliott, Md, MD
Emergency Medicine — Payments: $233.29
Dr. Terrell Caffery, Md, MD
Emergency Medicine — Payments: $192.24